These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3410145)

  • 1. [Studies on abnormalities of adrenal steroidogenesis in essential hypertension, primary aldosteronism and renovascular hypertension: responses of plasma steroids to angiotensin III].
    Itoh N
    Nihon Naibunpi Gakkai Zasshi; 1988 May; 64(5):419-38. PubMed ID: 3410145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of serum angiotensin I-converting enzyme in essential hypertension].
    Gotoh M
    Nihon Naibunpi Gakkai Zasshi; 1985 Dec; 61(12):1341-57. PubMed ID: 3005063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The syndromes of low-renin hypertension: "separating the wheat from the chaff".
    Kater CE; Biglieri EG
    Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):674-81. PubMed ID: 15761538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.
    Carey RM; Ayers CR; Vaughan ED; Peach MJ; Herf SM
    J Clin Invest; 1979 Apr; 63(4):718-26. PubMed ID: 438332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Corticoid secretion in primary aldosteronism. II. The renin releasing test and the angiotensin II analog infusion test (author's transl)].
    Nigawara K; Yagihashi Y; Kogawa T; Sugawara S; Kawamata A; Hitomi H; Tulachan Y; Funyu T; Terayama Y; Furusawa M; Morita S; Kido K; Tanaka T; Eba H
    Nihon Naibunpi Gakkai Zasshi; 1980 Jan; 56(1):47-56. PubMed ID: 6987096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
    Witzgall H; Lorenz R; von Werder K; Weber PC
    Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid increase of mineralocorticoids after furosemide in low-renin essential hypertension: evidence for 18-hydroxycorticosterone to be a better marker than aldosterone.
    Witzgall H; Thayil G; Weber PC
    Klin Wochenschr; 1982 Aug; 60(16):847-52. PubMed ID: 6752560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin III on blood pressure, renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Suzuki S; Doi Y; Aoi W; Kuramochi M; Hashiba K
    Jpn Heart J; 1984 Jan; 25(1):75-85. PubMed ID: 6376863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary kallikrein excretion in essential and mineralocorticoid hypertension.
    Holland OB; Chud JM; Braunstein H
    J Clin Invest; 1980 Feb; 65(2):347-56. PubMed ID: 7356684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exaggerated blood pressure response to angiotensin II in patients with Cushing's syndrome due to adrenocortical adenoma.
    Yasuda G; Shionoiri H; Umemura S; Takasaki I; Ishii M
    Eur J Endocrinol; 1994 Dec; 131(6):582-8. PubMed ID: 7804440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of urinary PGE2 and renin-angiotensin-aldosterone system in the pathogenesis of essential hypertension.
    Ruilope L; Garcia Robles R; Barrientos A; Bernis C; Alcazar J; Tresguerres JA; Mancheño E; Millet VG; Sancho J; Rodicio JL
    Clin Exp Hypertens A; 1982; 4(6):989-1000. PubMed ID: 7047008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of several adrenal steroids to ACTH stimulation in essential hypertension.
    Honda M; Nowaczynski W; Guthrie GP; Messerli FH; Tolis G; Kuchel O; Genest J
    J Clin Endocrinol Metab; 1977 Feb; 44(2):264-72. PubMed ID: 190252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioactive 86rubidium influx into red blood cells in essential hypertension in relation to the plasma renin activity.
    Horký K; Schreiber V; Pribyl T
    Horm Metab Res; 1984 Jan; 16(1):41-5. PubMed ID: 6365716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in responses of blood pressure and several hormones to infusions of angiotensin II and angiotensin III in patients with essential hypertension].
    Manabe R; Honda M; Hatano M
    Nihon Naibunpi Gakkai Zasshi; 1984 May; 60(5):659-71. PubMed ID: 6092161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
    Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
    J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension.
    Yamamoto Y
    Jpn Heart J; 1975 Jul; 16(4):404-20. PubMed ID: 1152295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin III (DES-1-asp-angiotensin II) and angiotensin III analogue (DES-1-asp-8-ile-angiotensin II) upon adrenal steroidogenesis and blood pressure.
    Saruta T; Saito I; Nakamura R; Nitta M; Oka M
    Jpn Circ J; 1977 Aug; 41(8):887-94. PubMed ID: 198594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro studies on steroid metabolism in a case of primary aldosteronism with multiple lesions of adenoma and nodular hyperplasia.
    Honda M; Tsuchiya M; Tamura H; Watanabe H; Izumi Y; Hatano M; Shiratsuchi T; Den K; Kawaoi A; Okano T
    Endocrinol Jpn; 1982 Oct; 29(5):529-40. PubMed ID: 6303762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.